CAS 958852-01-2: GSK1059615
Formula:C18H11N3O2S
- Synonyms:
- Gsk 1059615
- 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione
- (5Z)-5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidinedione
- (Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK1059615 REF: IN-DA005WY2CAS: 958852-01-2 | 98% | 96.00 €~607.00 € | Thu 17 Apr 25 |
 | GSK1059615 REF: 54-BUP05792CAS: 958852-01-2 | 98% | 299.00 €~754.00 € | Mon 21 Apr 25 |
 | GSK1059615 REF: TM-T2357CAS: 958852-01-2 | ≥95% - ≥95% | 46.00 €~505.00 € | Thu 24 Apr 25 |
 | GSK 1059615 REF: TR-G797803CAS: 958852-01-2 | - - - | 3,825.00 € | Wed 28 May 25 |
 | (Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione REF: 3D-FP43332CAS: 958852-01-2 | Min. 95% | - - - | Discontinued product |
GSK1059615
CAS:958852-01-2
Formula:
C18H11N3O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
333.36384000000004
Ref: IN-DA005WY2
| 5mg | 96.00 € | ||
| 10mg | 114.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
Ref: 54-BUP05792
| 25mg | 299.00 € | ||
| 50mg | 523.00 € | ||
| 100mg | 754.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
GSK1059615
CAS:958852-01-2
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, …
Formula:
C18H11N3O2S
Purity:
≥95% - ≥95%
Color and Shape:
Solid
Molecular weight:
333.36
Ref: TM-T2357
| 2mg | 46.00 € | ||
| 5mg | 66.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 192.00 € | ||
| 50mg | 350.00 € | ||
| 100mg | 505.00 € | ||
| 1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
GSK 1059615
Controlled ProductCAS:958852-01-2
Formula:
C18H11N3O2S
Color and Shape:
Neat
Molecular weight:
333.364
Ref: TR-G797803
| 250mg | 3,825.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025
(Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione
CAS:958852-01-2
(Z)-5-((4-(Pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione is a potent inhibitor of the epidermal growth factor receptor (EGFR). It has been …
Purity:
Min. 95%
Ref: 3D-FP43332
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
